Multicenter study of [18F]-THK-5351 PET in tauopathies

Multicenter study of [18F]-THK-5351 PET in tauopathies - [18F]-THK-5351 PET in tauopathies

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022949

Enrollment

100

Registered

2016-07-01

Start date

2016-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tauopathy

Interventions

PET examination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinical suspicious of tauopathy

Exclusion criteria

Exclusion criteria: #brain infarction, hydrocephalus, metabolic disorder, tumor, inflammation #claustrophobia #cardiac pacemaker insertion, metabolic insertion, tatoo #attending other study including nuclear medicine examination #decision made by attending physician #denying to get the results of examinations

Design outcomes

Primary

Measure	Time frame
Distribution pattern of [18F]-THK-5351 in each tauopathy.	—

Countries

Japan

Contacts

Public ContactHARUMASA TAKANO

National Center of Neurology and Psychiatry Integrative Brain Imaging Center

hrtakano@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026